Krilax AI Clinic Platform | Version 2.0 | Effective: March 2026
Krilax Innovations Private Limited ("Company", "we", "us", "our")
1.1. "Platform" means the Krilax AI Clinic software-as-a-service application, including all web-based interfaces, APIs, backend services, and associated documentation provided by the Company.
1.2. "Subscriber" or "You" means the individual, clinic, hospital, or organization that registers for and uses the Platform.
1.3. "Authorized User" means any individual (doctor, staff, administrator) granted access to the Platform by the Subscriber.
1.4. "AI Features" means all artificial intelligence and machine learning capabilities of the Platform, including but not limited to prescription suggestions, diagnosis hints, patient symptom analysis, report analysis, drug interaction checks, and any other AI-assisted content generation.
1.5. "Patient Data" means any personal information, medical records, health data, consultation notes, prescriptions, lab reports, and any other data relating to patients entered into or generated by the Platform.
1.6. "Prescriber" means any registered medical practitioner who uses the Platform to generate, review, or issue prescriptions, diagnoses, or treatment plans to patients.
1.7. "Confidential Information" means all proprietary information disclosed by either party including business processes, algorithms, technical data, and trade secrets.
2.1. The Platform provides healthcare practice management tools including patient registration, queue management, consultation records, AI-assisted prescription suggestions, PDF prescription generation, patient report analysis, analytics dashboards, and related healthcare workflow features.
2.2. The Platform is hosted on enterprise-grade cloud infrastructure located in India. All data processing, storage, and computation occurs within Indian data centres in compliance with data localization requirements.
2.3. The Platform is a practice management tool only. It is not a medical device, diagnostic tool, or clinical decision support system as defined under applicable medical device regulations. The Company makes no representations that the Platform is certified, approved, or registered as a medical device under any jurisdiction.
2.4. Access to the Platform requires a compatible web browser and a stable internet connection. The Company does not guarantee compatibility with all devices, browsers, or network configurations.
2.5. The Company reserves the right to modify, enhance, or discontinue any feature of the Platform at any time without prior notice, provided that such changes do not materially diminish the core functionality available under an active paid subscription.
3.1. Subscription plans are priced on a per-doctor, per-month basis. The total subscription cost is determined by the number of registered doctors and the billing cycle selected by the Subscriber.
3.2. All payments are processed securely through Razorpay or such other payment gateway as the Company may designate. All prices are denominated in Indian Rupees (INR).
3.3. Goods and Services Tax (GST) at the prevailing rate (currently 18%) is applicable on all subscription fees as per Indian tax law (SAC Code: 998314 — Information Technology Software Services).
3.4. A payment gateway processing fee (currently 2%) may be charged to cover transaction costs. This fee is subject to change based on payment gateway provider terms.
3.5. Subscription fees are strictly non-refundable. No refunds shall be issued for partial use, early termination, downgrade requests, or dissatisfaction with the service. Upon plan upgrade during an active billing cycle, unused days from the current plan shall be credited on a pro-rata basis towards the upgraded plan.
3.6. Plan downgrades are not permitted during an active billing cycle. Subscribers may choose not to renew or may select a different plan at the time of renewal.
3.7. The Company reserves the right to modify pricing, plan structures, and fee schedules at any time. While the Company endeavours to provide reasonable advance notice of material pricing changes to active subscribers, it is under no obligation to provide any minimum notice period. Continued use of the Platform after a pricing change constitutes acceptance of the revised pricing.
3.8. Free trial periods (where offered) provide full access to plan features for the specified duration. No credit card or payment information is required for trial registration. The Company reserves the right to modify or discontinue trial offerings at any time.
3.9. Failure to pay subscription fees by the due date may result in immediate suspension or restriction of access to the Platform. The Company shall not be liable for any data loss or business interruption arising from such suspension.
CRITICAL MEDICAL DISCLAIMER — PLEASE READ CAREFULLY
4.1. All AI-generated content on this Platform — including but not limited to prescription suggestions, diagnosis hints, drug recommendations, dosage calculations, drug interaction alerts, differential diagnoses, and treatment plans — is strictly advisory in nature and is intended solely to assist qualified, licensed medical practitioners.
4.2. The Prescriber bears complete, sole, and non-delegable responsibility for every medical decision, prescription, diagnosis, and treatment plan issued to any patient. Under no circumstances does the use of AI Features transfer, diminish, or share this responsibility with the Company, its affiliates, employees, agents, or technology partners.
4.3. AI models are powered by machine learning algorithms that may produce inaccurate, incomplete, outdated, clinically inappropriate, or potentially harmful suggestions. AI outputs may not account for the patient's complete medical history, concurrent medications, allergies, contraindications, genetic factors, or the latest clinical guidelines. Every AI suggestion must be independently verified and validated by the Prescriber against their professional judgment and clinical examination findings before being prescribed or communicated to any patient.
4.4. The Company, its directors, officers, employees, affiliates, technology partners, and service providers are expressly excluded from all liability — whether in contract, tort (including negligence), strict liability, or otherwise — for any adverse clinical outcomes, misdiagnoses, medication errors, adverse drug reactions, drug interactions, allergic reactions, patient harm, injury, death, or any other consequence arising directly or indirectly from reliance on AI-generated content.
4.5. By activating and using the AI Features, the Prescriber warrants and represents that they: (a) possess all requisite medical qualifications, licensing, and registration as mandated by the National Medical Commission Act, 2019, the Indian Medical Council Act, 1956, and all applicable state medical council regulations; (b) maintain active and valid medical registration; and (c) are competent to independently evaluate and override any AI-generated suggestion.
4.6. The Platform is not a substitute for professional medical education, clinical training, in-person patient examination, diagnostic testing, or established evidence-based medical protocols. The Prescriber must exercise the same standard of care as would apply in the absence of AI assistance.
4.7. The AI models are periodically updated and retrained. The Company does not guarantee the consistency, accuracy, or clinical validity of AI outputs across different versions. Past accuracy of AI suggestions does not guarantee future accuracy.
AI-ASSISTED ANALYSIS DISCLAIMER
5.1. The Platform may provide AI-assisted analysis of patient symptoms, lab reports, imaging reports, and other clinical data ("Analysis Features"). These analyses are preliminary, machine-generated interpretations only and do not constitute medical diagnoses or clinical opinions.
5.2. Patient symptom notes, history summaries, and clinical observations generated by the Platform are AI-generated drafts that must be reviewed, edited, and validated by the treating physician before being relied upon for any clinical decision.
5.3. Lab report interpretations, abnormal value flagging, and trend analyses provided by the Platform are based on general reference ranges and may not account for patient-specific variables including age, gender, ethnicity, pregnancy status, concurrent conditions, or laboratory-specific calibration differences.
5.4. The Prescriber must independently verify all AI-generated analysis against original source documents (lab reports, imaging studies, patient-reported symptoms) and their own clinical assessment. The Company accepts no responsibility for clinical decisions made based on AI-generated analysis without independent verification by the Prescriber.
5.5. The Platform does not provide real-time critical value alerts for life-threatening conditions. Prescribers must rely on their own clinical judgment and established emergency protocols for urgent medical situations.
INDEMNIFICATION & HOLD HARMLESS
6.1. The Prescriber and the Subscriber jointly and severally agree to indemnify, defend, and hold harmless the Company, its directors, officers, employees, affiliates, agents, and service providers from and against any and all claims, demands, actions, suits, proceedings, losses, damages, liabilities, costs, and expenses (including reasonable legal fees and court costs) arising from or related to:
6.2. The Subscriber acknowledges that the Company provides a technology platform only and does not practice medicine, provide medical advice, or establish a doctor-patient relationship with any patient. The entire doctor-patient relationship, duty of care, and clinical responsibility rests exclusively with the Prescriber.
6.3. The Prescriber shall maintain adequate professional indemnity insurance as required by applicable medical regulations and shall not rely on this Platform as a defence in any malpractice proceeding.
6.4. This indemnification obligation shall survive the termination or expiration of the Subscriber's account and these Terms.
7.1. THE PLATFORM IS PROVIDED ON AN "AS IS" AND "AS AVAILABLE" BASIS WITHOUT WARRANTIES OF ANY KIND, whether express, implied, or statutory, including but not limited to warranties of merchantability, fitness for a particular purpose, accuracy, completeness, non-infringement, and any warranties arising from course of dealing or usage of trade.
7.2. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, THE COMPANY'S AGGREGATE LIABILITY FOR ALL CLAIMS ARISING UNDER OR IN CONNECTION WITH THESE TERMS SHALL NOT EXCEED THE TOTAL SUBSCRIPTION FEES ACTUALLY PAID BY THE SUBSCRIBER IN THE TWELVE (12) MONTHS IMMEDIATELY PRECEDING THE EVENT GIVING RISE TO THE CLAIM.
7.3. IN NO EVENT SHALL THE COMPANY BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, PUNITIVE, OR EXEMPLARY DAMAGES, INCLUDING BUT NOT LIMITED TO DAMAGES FOR LOSS OF PROFITS, REVENUE, DATA, GOODWILL, BUSINESS OPPORTUNITY, OR ANTICIPATED SAVINGS, EVEN IF THE COMPANY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
7.4. The Company shall not be liable for any loss, damage, or delay arising from events beyond its reasonable control, including but not limited to acts of God, natural disasters, pandemics, government actions, armed conflict, terrorism, civil unrest, internet or telecommunications failures, power outages, third-party service provider failures (including but not limited to cloud infrastructure providers, Razorpay, and communication service providers), cyberattacks, or any other force majeure event.
7.5. The limitations and exclusions in this Section shall apply regardless of the legal theory on which the claim is based, whether in contract, tort, negligence, strict liability, warranty, or otherwise, and shall survive the termination of these Terms.
8.1. Patient Data is classified as sensitive personal data under the Digital Personal Data Protection Act, 2023 ("DPDP Act") and the Information Technology Act, 2000. Such data is processed solely for the purpose of providing healthcare management services through the Platform.
8.2. All data is encrypted in transit using TLS 1.2 or higher and encrypted at rest using AES-256 encryption. Data is stored in secure cloud data centres located in India.
8.3. The Company does not sell, rent, lease, or share Patient Data with any third party for marketing, advertising, analytics, or any non-service purpose.
8.4. The Subscriber (clinic/hospital) is the Data Fiduciary (data controller) under the DPDP Act. The Company acts as a Data Processor and processes data only as instructed by the Subscriber and as necessary to provide the Platform services.
8.5. Data retention follows applicable Indian healthcare regulations, the IT Act 2000, the DPDP Act 2023, and any sector-specific guidelines issued by the National Medical Commission or relevant regulatory bodies.
8.6. The Subscriber may request complete data export (in machine-readable format) or deletion of their data by submitting a written request to contact@krilax.com. Data export requests are processed within fifteen (15) business days. Data deletion requests are processed within thirty (30) business days, subject to legal retention requirements.
8.7. The Company implements industry-standard security measures including role-based access control (RBAC), JWT-based authentication, audit logging, encrypted storage, network isolation, and periodic security assessments. However, no system is completely secure, and the Company cannot guarantee absolute security of data.
8.8. In the event of a data breach that affects Patient Data, the Company shall notify the affected Subscriber within seventy-two (72) hours of becoming aware of the breach, along with details of the nature of the breach, the data affected, and remedial measures taken.
8.9. The Company may use anonymized, aggregated, de-identified data for the purpose of improving the Platform, training AI models, generating industry benchmarks, and conducting research, provided that such data cannot be used to identify any individual patient or Subscriber.
9.1. The Subscriber is responsible for maintaining the confidentiality and security of all account credentials, including passwords and access tokens. The Subscriber must immediately notify the Company of any suspected unauthorized access.
9.2. Authorized Users must not share login credentials with any other person. Each user must have their own unique account. The Subscriber is responsible for all activities conducted under its Authorized User accounts.
9.3. The Platform must be used exclusively for legitimate healthcare practice management purposes. The following uses are strictly prohibited:
9.4. The Subscriber's account may be immediately suspended or terminated, without prior notice, for non-payment, security violations, breach of these Terms, or activities that threaten the integrity or availability of the Platform.
10.1. All intellectual property rights in the Platform — including source code, algorithms, AI models, user interface designs, documentation, trademarks, and trade secrets — are and shall remain the exclusive property of the Company.
10.2. The Subscriber is granted a limited, non-exclusive, non-transferable, revocable licence to use the Platform for the duration of their active subscription, solely for its intended purpose.
10.3. The Subscriber retains ownership of all Patient Data entered into the Platform. The Company claims no ownership over Patient Data.
10.4. Feedback, suggestions, or feature requests submitted by the Subscriber may be freely used by the Company to improve the Platform without obligation of compensation or attribution.
11.1. The Company shall use commercially reasonable efforts to maintain Platform availability. However, the Company does not guarantee any specific uptime percentage or service level agreement (SLA) unless separately agreed in writing.
11.2. Scheduled maintenance may be performed with reasonable advance notice. Emergency maintenance may be performed without prior notice when necessary to protect the integrity, security, or availability of the Platform.
11.3. The Company is not responsible for downtime caused by factors outside its control, including internet connectivity issues at the Subscriber's end, browser incompatibilities, or third-party service outages.
12.1. The Subscriber may discontinue use of the Platform at any time by not renewing their subscription. No refund shall be issued for the unused portion of a prepaid subscription period.
12.2. The Company may terminate or suspend a Subscriber's account immediately and without notice for: (a) material breach of these Terms; (b) non-payment of fees; (c) fraudulent, illegal, or abusive activity; (d) a court order or regulatory directive.
12.3. Upon termination, the Subscriber's access to the Platform shall be immediately revoked. The Subscriber may request data export within thirty (30) days of termination, after which the Company may permanently delete all Subscriber data.
12.4. Sections relating to limitation of liability, indemnification, intellectual property, data obligations, and governing law shall survive termination of these Terms.
13.1. The Company reserves the right to amend, modify, or update these Terms at any time at its sole discretion. Material changes shall be communicated to Subscribers via email or in-Platform notification.
13.2. Continued use of the Platform after the effective date of any amendment constitutes the Subscriber's acceptance of the revised Terms. If the Subscriber does not agree to the amended Terms, their sole remedy is to discontinue use of the Platform.
13.3. The most current version of these Terms is always available at the Platform's Terms of Service page.
14.1. These Terms shall be governed by and construed in accordance with the laws of India, without regard to conflict of law principles.
14.2. Any dispute, controversy, or claim arising out of or in connection with these Terms, or the breach, termination, or invalidity thereof, shall first be attempted to be resolved through good-faith negotiation between the parties for a period of thirty (30) days.
14.3. If the dispute cannot be resolved through negotiation, it shall be referred to and finally resolved by arbitration in accordance with the Arbitration and Conciliation Act, 1996 (as amended). The seat of arbitration shall be Pune, Maharashtra, India. The arbitration shall be conducted in English by a sole arbitrator mutually appointed by the parties.
14.4. Notwithstanding the above, either party may seek injunctive or other equitable relief from any court of competent jurisdiction to prevent irreparable harm. The courts in Pune, Maharashtra, India shall have exclusive jurisdiction for such proceedings.
15.1. Entire Agreement. These Terms, together with any order forms and policies referenced herein, constitute the entire agreement between the parties and supersede all prior agreements, understandings, and representations.
15.2. Severability. If any provision of these Terms is held to be invalid, illegal, or unenforceable, the remaining provisions shall continue in full force and effect.
15.3. Waiver. The failure of the Company to enforce any right or provision of these Terms shall not constitute a waiver of such right or provision.
15.4. Assignment. The Subscriber may not assign or transfer these Terms or any rights hereunder without the prior written consent of the Company. The Company may assign these Terms without restriction.
15.5. Notices. All notices under these Terms shall be sent to the email address associated with the Subscriber's account or to legal@krilax.com for notices to the Company.
15.6. Independent Contractors. The parties are independent contractors. Nothing in these Terms creates a partnership, joint venture, agency, or employment relationship.
Krilax Innovations Private Limited
For legal inquiries: legal@krilax.com
For support: contact@krilax.com
Version 2.0 | Last updated: March 2026